HIGHLIGHTS
- who: Strahlenther Onkol ( and colleagues from the Department of Radiation Oncology, Technical University Germany have published the research: ORIGINAL ARTICLE, in the Journal: (JOURNAL)
- what: The authors report on toxicity incidence and outcome of tomotherapy with a focus on multitarget RT (mtRT). More precisely, this study shows an excellent 5-year survival rate of 55.6% ± 18.7% for patients with primary disease multifocal Ewing sarcoma receiving mtRT, especially when compared to the 3-year OS of only 34% ± 4% for multifocal Ewing sarcoma demonstrated by Ladenstein et_al and the 3-year OS of 40 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.